Medical Search

Medical News from Wall Street Journal

FDA Appears to Back HIV Drug

May 8, 2012, 9:09 am by Wall Street Journal

The FDA appeared to support the use of a Gilead HIV drug in healthy people to help prevent them from contracting the virus that causes AIDS.


Featured Medical Stories

Fitbit Flex Sleep Sensor Tracker

Will health sensors make humans immortal?

Not so fast! We need to get from here to there. Today, health/behavior monitoring and quantification sensors are all the rage. The Fitbit, a wearable sensor, is one of the more popular wearable tech devices for tracking your health. Fitbit tracks your activity (steps), diet, and even your sleep patterns. You can interact with the Fitbit using a series of tapping sequences and the Fitbit syncs all your data with your phone and computer. Then the process is to quantify, analyze, and optimize your wake and sleep life. Doing all this will not help you avoid your ultimate demise, but it could contribute to a longer life and better yet, one where you're in better health along your life's time-line. The concept is that if you are monitoring your activity, food, and sleep, you can make adjustments to improve these areas; thus better health. The Fitbit Flex is only $99! Get started Buy directly from Fitbit

Learn more at Fitbit's Official Website HOT! Fitbit Accessories & New Products Google Fitbit
Matcha Green Tea Super Food Antioxidants

Matcha Green Tea King of Superfoods

Matcha Green Tea is the latest superfood that celebs and regular folk are finding give them supercharged antioxidant purification with a non-jittery sense of focus. Most matcha available to buy is in very small sizes and is not high enough quality. It is important that you buy high quality matcha. We've found bulk high quality 100% natural matcha green tea imported from Japan. Learn more here: Japanese Matcha Green Tea in bulk here on Amazon

High Quality Matcha Find Matcha on Amazon Google Matcha Green Tea

More medical news from Wall Street Journal

NantKwest Gives Biotech Another Big IPO
Wall Street Journal : July 28, 2015, 8:28 am
These days, a biotech company doesn’t need an approved drug to be worth several billion dollars.

Merck Earnings Hurt by Arthritis Drug Knockoffs
Wall Street Journal : July 28, 2015, 7:52 am
Low-cost knockoffs of the arthritis treatment Remicade in Europe hurt Merck & Co.’s second-quarter sales and earnings, a harbinger of the pressure facing sellers of costly biotechnology drugs in coming years.

New Strategies Deployed in Abortion Battle
Wall Street Journal : July 28, 2015, 7:49 am
As the fight between antiabortion activists and abortion-rights supporters about the use of fetal tissue in medical research enters its third week, both sides have shifted tactics in their battle.

U.S. Health-Spending Growth Jumped to 5.5% in 2014
Wall Street Journal : July 28, 2015, 6:20 am
Growth in national health spending, which had dropped to historic lows in recent years, has snapped back and is set to continue at a faster pace over the next decade, federal actuaries said.

Gilead Sales Soar on Hepatitis Drugs
Wall Street Journal : July 28, 2015, 1:22 am
Gilead Sciences said its two key hepatitis C drugs, Sovaldi and Harvoni, generated about $4.9 billion in sales in the second quarter, topping Wall Street estimates.